In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
 Anna Giulia Pavon
Anna Giulia Pavon
Anna Giulia Pavon Anna Giulia Pavon

University Hospital Centre Vaudois (CHUV), Lausanne (Switzerland)

Specialities : Cardiac Magnetic Resonance , Valvular Heart Disease

7 presentations from this speaker

Increased interstitial fibrosis in patients with mitral valve prolapse and mitro-annular dysjunction

Event : EuroEcho 2019

  • Session : Multi-modality imaging in valvular heart disease
  • Speaker : A Pavon (Lausanne,CH)

Optimal timing for cardiovascular magnetic resonance after ST-segment elevation myocardial infarction for effective risk stratification

Event : EuroCMR 2019

  • Session : Moderated ePosters session 2: frontiers in viability imaging
  • Speaker : A Pavon (Lausanne,CH)

A murmur in an asymptomatic 60 years old woman: an unusual presentation of ALCAPA syndrome

Event : EuroEcho 2017

  • Session : Clinical Case Poster session 2
  • Speaker : A Pavon (Lausanne,CH)

Fulminant Myocarditis treated with combined implantation of left and right percutaneous ventricular assist devices

Event : ESC Congress 2017

  • Session : Acute cardiac care: expect the unexpected!
  • Speaker : A Pavon (Lausanne,CH)

Members get more

Join now
  • 1ESC Professional Members – access all resources from general ESC events 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are